UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

KEYNOTE-048: Progression after the next line of therapy following pembrolizumab (P) or P plus chemotherapy (P+C) vs EXTREME (E) as first-line (1L) therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6505-6505

2020

Volltextzugriff (PDF)

MDAPlatform: A Component-based Platform for Constructing and Assessing miRNA-disease Association Prediction Methods

Current bioinformatics, 2021-01, Vol.16 (5), p.710-721

2021

Volltextzugriff (PDF)

Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.6000-6000

2019

Volltextzugriff (PDF)

Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma

Blood, 2017-07, Vol.130 (3), p.267-270

2017

Volltextzugriff (PDF)

Predicting Drug-Drug Interactions Based on Integrated Similarity and Semi-Supervised Learning

IEEE/ACM transactions on computational biology and bioinformatics, 2022-01, Vol.19 (1), p.168-179

2022

Volltextzugriff (PDF)

Based on network pharmacology and molecular docking to explore the mechanism of the treatment of IBD by Pteris multifida Poir

Jiangxi nongye daxue xuebao = Acta agriculturae universitatis jiangxiensis, 2024-06, Vol.46 (3), p.701-712

2024

Volltextzugriff (PDF)

Pembrolizumab for myelodysplastic syndromes after failure of hypomethylating agents in the phase 1b KEYNOTE-013 study

Leukemia & lymphoma, 2022-06, Vol.63 (7), p.1660-1668

2022

Volltextzugriff (PDF)

Phase III study evaluating efficacy and safety of MK-6482 + lenvatinib versus cabozantinib for second- or third-line therapy in patients with advanced renal cell carcinoma (RCC) who progressed after prior anti-PD-1/L1 therapy

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.TPS372-TPS372

2021

Volltextzugriff (PDF)

Research progress on remote sensing assessment of lake nutrient status and retrieval algorithms of characteristic parameters

Yao gan xue bao, 2022, Vol.26 (1), p.77-91

2022

Volltextzugriff (PDF)

Further clinical interpretation and implications of KEYNOTE-048 findings – Authors' reply

The Lancet (British edition), 2020-08, Vol.396 (10248), p.379-380

2020

Volltextzugriff (PDF)

Terrestrial dissolved organic matter inputs accompanied by dissolved oxygen depletion and declining pH exacerbate CO2 emissions from a major Chinese reservoir

Water research (Oxford), 2024-03, Vol.251, p.121155-121155, Article 121155

2024

Volltextzugriff (PDF)

LITESPARK-011: belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy

Future oncology (London, England), 2023-01, Vol.19 (2), p.113-121

2023

Volltextzugriff (PDF)

Coformulated quavonlimab and pembrolizumab (pembro) in combination with lenvatinib (lenva) as first-line (1L) therapy for patients (pts) with advanced hepatocellular carcinoma (HCC): Phase 2 KEYSTEP-004 study

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.484-484

2024

Volltextzugriff (PDF)

PS3-3 Pembrolizumab + chemoradiation therapy for locally advanced head and neck squamous cell carcinoma (HNSCC): KEYNOTE-412

Annals of oncology, 2023-11, Vol.34, p.S1380-S1380

2023

Volltextzugriff (PDF)

Terrestrial dissolved organic matter inputs accompanied by dissolved oxygen depletion and declining pH exacerbate CO 2 emissions from a major Chinese reservoir

Water research (Oxford), 2024-03, Vol.251, p.121155

2024

Volltextzugriff (PDF)

IDNDDI: An Integrated Drug Similarity Network Method for Predicting Drug-Drug Interactions

Bioinformatics Research and Applications, 2019, p.89-99

2019

Volltextzugriff (PDF)

Pembrolizumab, a PD-1 Inhibitor, in Patients with Myelodysplastic Syndrome (MDS) after Failure of Hypomethylating Agent Treatment

Blood, 2016-12, Vol.128 (22), p.345-345

2016

Volltextzugriff (PDF)

Phase 1b Study of Pembrolizumab in Patients with Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Results from the Ongoing Keynote-013 Trial

Blood, 2016-12, Vol.128 (22), p.619-619

2016

Volltextzugriff (PDF)

Controllable growth of ZnO nanorod arrays with different densities and their photoelectric properties

Nanoscale research letters, 2012-05, Vol.7 (1), p.246-246, Article 246

2012

Volltextzugriff (PDF)

Data normalization and clustering for big and small data and an application to clinical trials

Zhang, Yayan

2015

Volltextzugriff (PDF)

Optical absorption modulation in ZnO hemisphere nanorod arrays fabricated by nanoimprint lithography

International journal of nanomanufacturing, 2016, Vol.12 (3/4), p.286

2016

Volltextzugriff (PDF)

Chronic administration of ketamine induces cognitive deterioration by restraining synaptic signaling

Molecular psychiatry, 2021-09, Vol.26 (9), p.4702-4718

2021

Volltextzugriff (PDF)

Performance evaluation of activated carbon with different pore sizes and functional groups for VOC adsorption by molecular simulation

Chemosphere (Oxford), 2019-07, Vol.227, p.9-16

2019

Volltextzugriff (PDF)

TiL4‐Coordinated Black Phosphorus Quantum Dots as an Efficient Contrast Agent for In Vivo Photoacoustic Imaging of Cancer

Small (Weinheim an der Bergstrasse, Germany), 2017-03, Vol.13 (11), p.n/a

2017

Volltextzugriff (PDF)

In-situ gelation of sodium alginate supported on melamine sponge for efficient removal of copper ions

Journal of colloid and interface science, 2018-02, Vol.512, p.7-13

2018

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(181)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(139)
Life Sciences & Biomedicine
(90)
Physical Sciences
(46)
Humans
(40)
Chemistry
(34)
Technology
(30)
Male
(25)
Animals
(23)
Female
(22)
Adult
(15)
Materials Science
(15)
Middle Aged
(15)
Biochemistry & Molecular Biology
(14)
Proteins
(14)
Environmental Sciences & Ecology
(13)
Environmental Sciences
(12)
Materials Science, Multidisciplinary
(12)
Oncology
(12)
Science & Technology - Other Topics
(12)
Aged
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

KEYNOTE-048: Progression after the next line of therapy following pembrolizumab (P) or P plus chemotherapy (P+C) vs EXTREME (E) as first-line (1L) therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

MDAPlatform: A Component-based Platform for Constructing and Assessing miRNA-disease Association Prediction Methods

Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma

Predicting Drug-Drug Interactions Based on Integrated Similarity and Semi-Supervised Learning

Based on network pharmacology and molecular docking to explore the mechanism of the treatment of IBD by Pteris multifida Poir

Pembrolizumab for myelodysplastic syndromes after failure of hypomethylating agents in the phase 1b KEYNOTE-013 study

Phase III study evaluating efficacy and safety of MK-6482 + lenvatinib versus cabozantinib for second- or third-line therapy in patients with advanced renal cell carcinoma (RCC) who progressed after prior anti-PD-1/L1 therapy

Research progress on remote sensing assessment of lake nutrient status and retrieval algorithms of characteristic parameters

Further clinical interpretation and implications of KEYNOTE-048 findings – Authors' reply

Terrestrial dissolved organic matter inputs accompanied by dissolved oxygen depletion and declining pH exacerbate CO2 emissions from a major Chinese reservoir

LITESPARK-011: belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy

Coformulated quavonlimab and pembrolizumab (pembro) in combination with lenvatinib (lenva) as first-line (1L) therapy for patients (pts) with advanced hepatocellular carcinoma (HCC): Phase 2 KEYSTEP-004 study

PS3-3 Pembrolizumab + chemoradiation therapy for locally advanced head and neck squamous cell carcinoma (HNSCC): KEYNOTE-412

Terrestrial dissolved organic matter inputs accompanied by dissolved oxygen depletion and declining pH exacerbate CO 2 emissions from a major Chinese reservoir

IDNDDI: An Integrated Drug Similarity Network Method for Predicting Drug-Drug Interactions

Pembrolizumab, a PD-1 Inhibitor, in Patients with Myelodysplastic Syndrome (MDS) after Failure of Hypomethylating Agent Treatment

Phase 1b Study of Pembrolizumab in Patients with Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Results from the Ongoing Keynote-013 Trial

Controllable growth of ZnO nanorod arrays with different densities and their photoelectric properties

Data normalization and clustering for big and small data and an application to clinical trials

Optical absorption modulation in ZnO hemisphere nanorod arrays fabricated by nanoimprint lithography

Chronic administration of ketamine induces cognitive deterioration by restraining synaptic signaling

Performance evaluation of activated carbon with different pore sizes and functional groups for VOC adsorption by molecular simulation

TiL4‐Coordinated Black Phosphorus Quantum Dots as an Efficient Contrast Agent for In Vivo Photoacoustic Imaging of Cancer

In-situ gelation of sodium alginate supported on melamine sponge for efficient removal of copper ions

Suchergebnisse filtern